null
SMILES Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)nc3)c12)C1CCCN(C1)C(=O)C(Br)=C
InChI Key InChIKey=KCPKCAYWGNEVBR-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 8 hits for monomerid = 452963
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 428nMAssay Description:Preparation of Compounds to be Tested:1) Using DMSO to prepare 50× compound stock solutions (same as the stock solution in Example 34) for later use;...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase Blk(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.60nMAssay Description:Preparation of Compounds to be Tested:1) Using DMSO to prepare 50× compound stock solutions (same as the stock solution in Example 34) for later use;...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase CSK(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 180nMAssay Description:Preparation of Compounds to be Tested:1) Using DMSO to prepare 50× compound stock solutions (same as the stock solution in Example 34) for later use;...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.20nMAssay Description:The drug was dissolved in DMSO to make a 10 mM (mmol/L) stock solution, and the stock solution was then diluted to a drug solution with 50× test conc...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase HCK(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.00E+3nMAssay Description:Preparation of Compounds to be Tested:1) Using DMSO to prepare 50× compound stock solutions (same as the stock solution in Example 34) for later use;...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 901nMAssay Description:Preparation of Compounds to be Tested:1) Using DMSO to prepare 50× compound stock solutions (same as the stock solution in Example 34) for later use;...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 350nMAssay Description:Preparation of Compounds to be Tested:1) Using DMSO to prepare 50× compound stock solutions (same as the stock solution in Example 34) for later use;...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase Fgr(Homo sapiens (Human))
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
HANGZHOU HERTZ PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 27nMAssay Description:Preparation of Compounds to be Tested:1) Using DMSO to prepare 50× compound stock solutions (same as the stock solution in Example 34) for later use;...More data for this Ligand-Target Pair